Cohort Studies

Blood p‑tau217 Test Predicts Elevated 5‑ and 10‑Year Alzheimer’s Risk

A large pooled JAMA study shows very high plasma p‑tau217 levels identify people at much higher risk of future cognitive impairment and could reshape trial recruitment and early care if treatments prove effective.